GENERIC NAME:
Salbutamol + Beclometasone

THERAPEUTIC SEGMENT:
Anti-Asthmatic

INDICATIONS:
SCITIDE HFA inhaler is indicated for:

• The long-term management of Asthma when the need of inhaled corticosteroid and bronchodilator therapy has been established.
• The prevention of pathologies involving chronic obstructive bronchopneumopathy with asthmatic component.

BRIEF DESCRIPTION:

SCITIDE HFA inhaler contains Salbutamol, which belongs to a class of drugs known as bronchodilators and Beclometasone, which belongs to a class of drugs known as corticosteroids. It is used to treat and prevent wheezing and shortness of breath caused by breathing problems such as asthma. It works directly in the lungs to make breathing easier by reducing the irritation and swelling of the airways

DOSAGE FORM:
Metered Dose Inhaler
100 mcg + 50 mcg

PACK SIZE:
200 Metered doses